Crinetics Pharmaceuticals, Inc.
XNAS:CRNX
46.67
$48.95 - 70.00
$34.00 - 1.00
$46.65
$47.83
$47.52
$47.42
60.34
24.1
559533
1022500.1
88180862.12
Chart
TendieTensor AI Analysis
Company
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
Fundamentals
437
-10.290000
4.181680
-1.38
100
BBG00BC59224
BBG00BC592C3
94.18M
94.89M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own CRNX. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.